Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H20Cl2FN3O2 |
| Molecular Weight | 436.307 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C2=C(CCN3CCN(CC3)C4=CC(Cl)=CC(Cl)=C4)OC(=O)N2
InChI
InChIKey=VIASEBSYVIYYEZ-UHFFFAOYSA-N
InChI=1S/C21H20Cl2FN3O2/c22-15-11-16(23)13-18(12-15)27-9-7-26(8-10-27)6-5-19-20(25-21(28)29-19)14-1-3-17(24)4-2-14/h1-4,11-13H,5-10H2,(H,25,28)
| Molecular Formula | C21H20Cl2FN3O2 |
| Molecular Weight | 436.307 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2571727
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2571727
Lodiperon exhibited neuroleptic activity with very low liability to the extrapyramidal side effects. Its activity was greater than that of butropipazone and fluanisone, while of the same order of that of chlorpromazine; however, lodiperon showed a longer lasting activity and minor ability to produce catalepsy as compared with the reference drugs.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:10 GMT 2025
by
admin
on
Mon Mar 31 18:02:10 GMT 2025
|
| Record UNII |
T8593BT7B4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB08552MIG
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
72444-63-4
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
4866
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
161849
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
100000082017
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
T8593BT7B4
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
DTXSID00222745
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL73383
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY | |||
|
C66025
Created by
admin on Mon Mar 31 18:02:10 GMT 2025 , Edited by admin on Mon Mar 31 18:02:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |